Summary

The global bioimpedance analyzers market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2% from 2021 to 2026. Growth in this market is driven by the growing prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers.

“Multi-frequency bioimpedance analyzers segment to witness the highest growth during the forecast period.”
Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. The consumables segment is projected to grow at the highest CAGR during the forecast period. The increasing prevalence of diseases, the growing focus on drug discovery, and the rising R&D expenditure by pharmaceutical companies are the major factor supporting the growth of this segment.
“Wireless bioimpedance modality segment to register the highest growth in the bioimpedance analyzers market during the forecast period.”
Based on the modality, the bioimpedance analyzers market is segmented into wired bioimpedance analyzers and wireless bioimpedance analyzers. The wireless bioimpedance analyzers segment is projected to witness the highest growth in the bioimpedance analyzers market during the forecast period. The advancements in and the growing demand for wireless technologies are the major factors supporting the growth of this segment.
“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the bioimpedance analyzers market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising obesity rates in China, growing awareness about health and fitness, and the strong foothold of local players in Japan.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (32%), Tier 2(44%), and Tier 3 (24%)

• By Designation: C-level (30%), Director-level (34%), and Others (36%)

• By Region: North America (40%), Europe (28%), AsiaPacific(20%), and Rest of the World(12%)


List of Companies Profiled in the Report

• Omron Corporation (Japan)
• Tanita Corporation (Japan)
• InBody (South Korea)
• RJL Systems (US),
• seca GmbH & Co. KG (Germany)
• EVOLT 360 (Australia)
• SELVAS Healthcare (South Korea)
• Charder Electronic Co. Ltd. (China)
• Fook Tin Group Holding Ltd. (China)
• Bodystat Ltd. (UK), Maltron International (UK)
• Biotekna (Italy), Withings (France)
• Biodynamics Corporation (US)
• Akern (Italy)
• Xiaomi (China)
• Sino-Hero (Shenzhen)
• Bio-Medical Electronics Co., Ltd. (China)
• Lumsail Industrial Inc. (China)
• Guangzhou Beautylife Electronic Technology Co., Ltd. (China)
• Bioparhom (France)
Research Coverage
This report studies the bioimpedance analyzers market based on product, modality, application,end user,and region. The report also analyzes factors (such as drivers, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total bioimpedance analyzers market. The report forecasts the revenue of the market segments with respect to five major regions.


Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on bioimpedance analyzers products offered by the top 20 players in the bioimpedance analyzers market. The report analyzes the bioimpedance analyzers market by product, modality,application, end user,and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.

• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the bioimpedance analyzers market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the bioimpedance analyzers market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.3 MARKET SCOPE 28
1.3.1 MARKET SEGMENTATION 28
1.3.2 YEARS CONSIDERED FOR THE STUDY 28
1.4 CURRENCY 29
1.5 LIMITATIONS 29
1.6 MARKET STAKEHOLDERS 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 1 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Secondary sources 32
2.1.2 PRIMARY DATA 33
FIGURE 2 PRIMARY SOURCES 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 35
2.2 MARKET SIZE ESTIMATION 36
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 37
FIGURE 5 TOP-DOWN APPROACH 38
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 39
FIGURE 6 DATA TRIANGULATION METHODOLOGY 39
2.4 MARKET SHARE 39
2.5 ASSUMPTIONS FOR THE STUDY 40
2.6 COVID-19 SPECIFIC ASSUMPTIONS 40
2.7 RISK ASSESSMENT/FACTOR ANALYSIS 41
TABLE 1 RISK ASSESSMENT/FACTOR ANALYSIS 41
2.8 COVID-19 HEALTH ASSESSMENT 41
2.9 COVID-19 ECONOMIC ASSESSMENT 41
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 42

3 EXECUTIVE SUMMARY 44
FIGURE 9 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 44
FIGURE 10 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2021 VS. 2026 (USD MILLION) 45
FIGURE 11 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 45
FIGURE 12 BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2021 VS. 2026 (USD MILLION) 46
FIGURE 13 BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2021 VS. 2026 (USD MILLION) 47
4 PREMIUM INSIGHTS 48
4.1 BIOIMPEDANCE ANALYZERS MARKET OVERVIEW 48
FIGURE 14 INCREASING INCIDENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 48
4.2 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION 49
FIGURE 15 SEGMENTAL BODY MEASUREMENT SEGMENT ACCOUNTED FOR
THE LARGEST MARKET SHARE IN 2020 49
4.3 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT AND COUNTRY, 2020 49
FIGURE 16 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS DOMINATED
THE NORTH AMERICAN MARKET IN 2020 49
4.4 GEOGRAPHICAL SNAPSHOT OF THE BIOIMPEDANCE ANALYZERS MARKET 50
FIGURE 17 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 18 BIOIMPEDANCE ANALYZERS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 DRIVERS 51
5.2.1.1 Increasing prevalence of lifestyle diseases 51
5.2.1.2 Initiatives by governments and private organizations to promote healthy lifestyles 52
5.2.1.3 Growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers 52
5.2.2 OPPORTUNITIES 53
5.2.2.1 Emerging markets across the Asia Pacific and Latin America 53
5.2.3 CHALLENGES 53
5.2.3.1 Inconsistency in the accuracy of different bioimpedance analyzers 53
5.3 COVID-19 IMPACT ANALYSIS 53
5.4 RANGES/SCENARIOS 54
5.4.1 BIOIMPEDANCE ANALYZERS MARKET 54
FIGURE 19 PESSIMISTIC SCENARIO 54
FIGURE 20 OPTIMISTIC SCENARIO 54
FIGURE 21 REALISTIC SCENARIO 55
5.5 VALUE CHAIN ANALYSIS 55
FIGURE 22 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES 55
5.6 SUPPLY CHAIN ANALYSIS 56
FIGURE 23 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 57
5.7 PORTER’S FIVE FORCES ANALYSIS 57
5.7.1 THREAT OF NEW ENTRANTS 57
5.7.2 INTENSITY OF COMPETITIVE RIVALRY 57
5.7.3 BARGAINING POWER OF BUYERS 58
5.7.4 BARGAINING POWER OF SUPPLIERS 58
5.7.5 THREAT OF SUBSTITUTES 58
5.8 TECHNOLOGY ANALYSIS 58
5.9 REGULATORY LANDSCAPE 58
FIGURE 24 510(K) APPROVAL PROCESS 59
5.10 PATENT ANALYSIS 59
5.11 TRADE ANALYSIS 60
5.11.1 TRADE ANALYSIS FOR BIOIMPEDANCE ANALYZERS 60
TABLE 2 IMPORT DATA FOR BIOIMPEDANCE ANALYZERS, BY COUNTRY,
2016–2020 (USD MILLION) 60
TABLE 3 EXPORT DATA FOR BIOIMPEDANCE ANALYZERS, BY COUNTRY,
2016–2020 (USD MILLION) 60
5.12 PRICING ANALYSIS 61
TABLE 4 PRICE RANGE FOR BIOIMPEDANCE ANALYZERS 61
5.13 ECOSYSTEM ANALYSIS 61
5.13.1 ROLE IN ECOSYSTEM 62
FIGURE 25 KEY PLAYERS IN THE BIOIMPEDANCE ANALYZERS ECOSYSTEM 62
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 63
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR BIOIMPEDANCE ANALYZER MANUFACTURERS 63
5.14.2 REVENUE SHIFT FOR BIOIMPEDANCE ANALYZERS 63
6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT 64
6.1 INTRODUCTION 65
TABLE 5 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 65
TABLE 6 BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 65
6.2 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS 66
6.2.1 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS SEGMENT DOMINATED
THE MARKET IN 2020 66
TABLE 7 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION) 66
TABLE 8 MULTI-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION) 66
6.3 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS 67
6.3.1 INCREASING OBESE POPULATION TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 67
TABLE 9 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2017–2019 (USD MILLION) 67
TABLE 10 SINGLE-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION, 2020–2026 (USD MILLION) 67
6.4 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS 68
6.4.1 INCREASING PREVALENCE OF CHRONIC DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 68
TABLE 11 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2017–2019 (USD MILLION) 68
TABLE 12 DUAL-FREQUENCY BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 68
7 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY 69
7.1 INTRODUCTION 70
TABLE 13 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 70
TABLE 14 BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 70
7.2 WIRELESS BIOIMPEDANCE ANALYZERS 70
7.2.1 WIRELESS BIOIMPEDANCE ANALYZERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 70
TABLE 15 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2017–2019 (USD MILLION) 71
TABLE 16 WIRELESS BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 71
7.3 WIRED BIOIMPEDANCE ANALYZERS 71
7.3.1 BENEFITS OF WIRED DEVICES TO DRIVE THEIR DEMAND AMONG END USERS 71
TABLE 17 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2017–2019 (USD MILLION) 72
TABLE 18 WIRED BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 72
8 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION 73
8.1 INTRODUCTION 74
TABLE 19 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 74
TABLE 20 BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 74
8.2 SEGMENTAL BODY MEASUREMENT 74
8.2.1 SEGMENTAL BODY MEASUREMENT SEGMENT TO DOMINATE THE BIOIMPEDANCE ANALYZERS MARKET DURING THE FORECAST PERIOD 74
TABLE 21 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2017–2019 (USD MILLION) 75
TABLE 22 BIOIMPEDANCE ANALYZERS MARKET FOR SEGMENTAL BODY MEASUREMENT, BY REGION, 2020–2026 (USD MILLION) 75
8.3 WHOLE-BODY MEASUREMENT 75
8.3.1 INCREASING INCIDENCE OF METABOLIC DISORDERS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT 75
TABLE 23 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT,
BY REGION, 2017–2019 (USD MILLION) 76
TABLE 24 BIOIMPEDANCE ANALYZERS MARKET FOR WHOLE-BODY MEASUREMENT,
BY REGION, 2020–2026 (USD MILLION) 76
9 BIOIMPEDANCE ANALYZERS MARKET, BY END USER 77
9.1 INTRODUCTION 78
TABLE 25 BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 78
TABLE 26 BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 78
9.2 HOSPITALS 78
9.2.1 INCREASING AWARENESS OF HEALTH AND FITNESS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 78
TABLE 27 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS, BY REGION,
2017–2019 (USD MILLION) 79
TABLE 28 BIOIMPEDANCE ANALYZERS MARKET FOR HOSPITALS, BY REGION,
2020–2026 (USD MILLION) 79
9.3 FITNESS CLUBS AND WELLNESS CENTERS 79
9.3.1 FITNESS CLUBS AND WELLNESS CENTERS SEGMENT TO DOMINATE
THE BIOIMPEDANCE ANALYZERS MARKET 79
FIGURE 26 US: NUMBER OF HEALTH CLUBS, 2012–2019 80
TABLE 29 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2017–2019 (USD MILLION) 80
TABLE 30 BIOIMPEDANCE ANALYZERS MARKET FOR FITNESS CLUBS AND WELLNESS CENTERS, BY REGION, 2020–2026 (USD MILLION) 81
9.4 HOME USERS 81
9.4.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF
THIS END-USER SEGMENT 81
TABLE 31 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION,
2017–2019 (USD MILLION) 81
TABLE 32 BIOIMPEDANCE ANALYZERS MARKET FOR HOME USERS, BY REGION,
2020–2026 (USD MILLION) 82
9.5 OTHER END USERS 82
TABLE 33 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2017–2019 (USD MILLION) 82
TABLE 34 BIOIMPEDANCE ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2020–2026 (USD MILLION) 83
10 BIOIMPEDANCE ANALYZERS MARKET, BY REGION 84
10.1 INTRODUCTION 85
TABLE 35 BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2017–2019 (USD MILLION) 85
TABLE 36 BIOIMPEDANCE ANALYZERS MARKET, BY REGION,
2020–2026 (USD MILLION) 85
10.2 NORTH AMERICA 86
FIGURE 27 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT 86
TABLE 37 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2017–2019 (USD MILLION) 87
TABLE 38 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY, 2020–2026 (USD MILLION) 87
TABLE 39 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2017–2019 (USD MILLION) 87
TABLE 40 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT, 2020–2026 (USD MILLION) 88
TABLE 41 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2017–2019 (USD MILLION) 88
TABLE 42 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY, 2020–2026 (USD MILLION) 88
TABLE 43 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 89
TABLE 44 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 89
TABLE 45 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2017–2019 (USD MILLION) 89
TABLE 46 NORTH AMERICA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER, 2020–2026 (USD MILLION) 90
10.2.1 US 90
10.2.1.1 Increasing number of health clubs and fitness centers driving market growth in the US 90
TABLE 47 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 90
TABLE 48 US: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 91
TABLE 49 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 91
TABLE 50 US: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 91
TABLE 51 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 92
TABLE 52 US: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 92
TABLE 53 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 92
TABLE 54 US: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 93
10.2.2 CANADA 93
10.2.2.1 High prevalence of obesity in Canada to support market growth 93
TABLE 55 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 93
TABLE 56 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 94
TABLE 57 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 94
TABLE 58 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 94
TABLE 59 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 95
TABLE 60 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 95
TABLE 61 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 95
TABLE 62 CANADA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 96
10.3 EUROPE 96
TABLE 63 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 96
TABLE 64 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 97
TABLE 65 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 97
TABLE 66 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 97
TABLE 67 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 98
TABLE 68 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 98
TABLE 69 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 98
TABLE 70 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 99
TABLE 71 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 99
TABLE 72 EUROPE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 99
10.3.1 GERMANY 100
10.3.1.1 Germany is the largest market for bioimpedance analyzers in Europe 100
TABLE 73 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 100
TABLE 74 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 100
TABLE 75 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 101
TABLE 76 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 101
TABLE 77 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 101
TABLE 78 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 102
TABLE 79 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 102
TABLE 80 GERMANY: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 102
10.3.2 UK 103
10.3.2.1 UK is the second-largest market for bioimpedance analyzers
in Europe 103
TABLE 81 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 103
TABLE 82 UK: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 103
TABLE 83 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 104
TABLE 84 UK: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 104
TABLE 85 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 104
TABLE 86 UK: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 104
TABLE 87 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 105
TABLE 88 UK: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 105
10.3.3 FRANCE 105
10.3.3.1 Increasing obese population and rising prevalence of metabolic disorders to drive market growth in France 105
TABLE 89 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 106
TABLE 90 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 106
TABLE 91 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 106
TABLE 92 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 107
TABLE 93 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 107
TABLE 94 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 107
TABLE 95 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 108
TABLE 96 FRANCE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 108
10.3.4 REST OF EUROPE 108
TABLE 97 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 109
TABLE 98 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 109
TABLE 99 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 110
TABLE 100 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 110
TABLE 101 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 110
TABLE 102 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 110
TABLE 103 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 111
TABLE 104 ROE: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 111
10.4 ASIA PACIFIC 112
FIGURE 28 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET SNAPSHOT 112
TABLE 105 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY,
2017–2019 (USD MILLION) 113
TABLE 106 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY COUNTRY,
2020–2026 (USD MILLION) 113
TABLE 107 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 113
TABLE 108 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 114
TABLE 109 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 114
TABLE 110 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 114
TABLE 111 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2017–2019 (USD MILLION) 115
TABLE 112 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION, 2020–2026 (USD MILLION) 115
TABLE 113 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 115
TABLE 114 ASIA PACIFIC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 116
10.4.1 JAPAN 116
10.4.1.1 Strong presence of local players to drive market growth in Japan 116
TABLE 115 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 116
TABLE 116 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 116
TABLE 117 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 117
TABLE 118 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 117
TABLE 119 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 117
TABLE 120 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 118
TABLE 121 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 118
TABLE 122 JAPAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 118

10.4.2 CHINA 119
10.4.2.1 Increasing obese population to drive market growth in China 119
TABLE 123 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 119
TABLE 124 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 119
TABLE 125 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 120
TABLE 126 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 120
TABLE 127 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 120
TABLE 128 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 121
TABLE 129 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 121
TABLE 130 CHINA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 121
10.4.3 TAIWAN 122
10.4.3.1 Increasing incidence of lifestyle diseases to drive market growth
in Taiwan 122
TABLE 131 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 122
TABLE 132 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 122
TABLE 133 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 123
TABLE 134 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 123
TABLE 135 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 123
TABLE 136 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 124
TABLE 137 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 124
TABLE 138 TAIWAN: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 124
10.4.4 AUSTRALIA 125
10.4.4.1 Increasing obese population to drive market growth in Australia 125
TABLE 139 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 125
TABLE 140 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 125
TABLE 141 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 126
TABLE 142 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 126
TABLE 143 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 126
TABLE 144 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 127
TABLE 145 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 127
TABLE 146 AUSTRALIA: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 127
10.4.5 REST OF ASIA PACIFIC 128
TABLE 147 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 128
TABLE 148 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 128
TABLE 149 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 129
TABLE 150 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 129
TABLE 151 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 129
TABLE 152 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 130
TABLE 153 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 130
TABLE 154 ROAPAC: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 130
10.5 REST OF THE WORLD 131
TABLE 155 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2017–2019 (USD MILLION) 131
TABLE 156 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY PRODUCT,
2020–2026 (USD MILLION) 131
TABLE 157 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2017–2019 (USD MILLION) 132
TABLE 158 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY MODALITY,
2020–2026 (USD MILLION) 132
TABLE 159 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2017–2019 (USD MILLION) 132
TABLE 160 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY APPLICATION,
2020–2026 (USD MILLION) 133
TABLE 161 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2017–2019 (USD MILLION) 133
TABLE 162 ROW: BIOIMPEDANCE ANALYZERS MARKET, BY END USER,
2020–2026 (USD MILLION) 133
11 COMPETITIVE LANDSCAPE 134
11.1 OVERVIEW 134
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 134
TABLE 163 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE BIOIMPEDANCE ANALYZERS MARKET 134
11.3 MARKET SHARE ANALYSIS 135
TABLE 164 BIOIMPEDANCE ANALYZERS MARKET: DEGREE OF COMPETITION 135
11.4 COMPANY EVALUATION MATRIX 136
11.4.1 STARS 136
11.4.2 EMERGING LEADERS 136
11.4.3 PERVASIVE PLAYERS 136
11.4.4 PARTICIPANTS 136
FIGURE 29 COMPANY EVALUATION MATRIX: BIOIMPEDANCE ANALYZERS MARKET 137
11.5 COMPANY EVALUATION MATRIX (SMES/START-UPS) 138
11.5.1 PROGRESSIVE COMPANIES 138
11.5.2 STARTING BLOCKS 138
11.5.3 RESPONSIVE COMPANIES 138
11.5.4 DYNAMIC COMPANIES 138
FIGURE 30 COMPANY EVALUATION MATRIX: BIOIMPEDANCE ANALYZERS MARKET
(SMES & START-UPS) 139
11.6 COMPANY FOOTPRINT ANALYSIS 140
TABLE 165 OVERALL FOOTPRINT OF COMPANIES IN THE BIOIMPEDANCE ANALYZERS MARKET 140
TABLE 166 PRODUCT FOOTPRINT OF COMPANIES 141
TABLE 167 REGIONAL FOOTPRINT OF COMPANIES 142
12 COMPANY PROFILES 143
12.1 KEY PLAYERS 143
(Business Overview, Products/Solutions Offered, Recent Developments, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win)*
12.1.1 OMRON CORPORATION 143
TABLE 168 OMRON CORPORATION: BUSINESS OVERVIEW 143
FIGURE 31 OMRON CORPORATION: COMPANY SNAPSHOT (2020) 144
12.1.2 TANITA CORPORATION 146
TABLE 169 TANITA CORPORATION: BUSINESS OVERVIEW 146
12.1.3 INBODY CO., LTD. 149
TABLE 170 INBODY CO., LTD.: BUSINESS OVERVIEW 149
12.1.4 RJL SYSTEMS, INC. 151
TABLE 171 RJL SYSTEMS, INC.: BUSINESS OVERVIEW 151
12.1.5 SECA GMBH & CO. KG 153
TABLE 172 SECA GMBH & CO. KG: BUSINESS OVERVIEW 153
12.1.6 EVOLT 360 155
TABLE 173 EVOLT 360: BUSINESS OVERVIEW 155
12.1.7 SELVAS HEALTHCARE (FORMERLY KNOWN AS JAWON MEDICAL) 156
TABLE 174 SELVAS HEALTHCARE: BUSINESS OVERVIEW 156
12.1.8 FOOK TIN GROUP HOLDINGS LTD. 157
TABLE 175 FOOK TIN GROUP HOLDINGS LTD.: BUSINESS OVERVIEW 157
12.1.9 BODYSTAT LTD. 158
TABLE 176 BODYSTAT LTD.: BUSINESS OVERVIEW 158
12.1.10 CHARDER ELECTRONIC CO., LTD. 159
TABLE 177 CHARDER ELECTRONIC CO., LTD.: BUSINESS OVERVIEW 159
12.1.11 MALTRON INTERNATIONAL 160
TABLE 178 MALTRON INTERNATIONAL: BUSINESS OVERVIEW 160
*Business Overview, Products/Solutions Offered, Recent Developments, Winning Imperatives, Current Focus and Strategies, Threat From Competition, Right to Win might not be captured in case of unlisted companies.
12.2 START-UPS/SME PLAYERS 161
12.2.1 BIOTEKNA 161
TABLE 179 BIOTEKNA: COMPANY OVERVIEW 161
12.2.2 BIODYNAMICS CORPORATION 161
TABLE 180 BIODYNAMICS CORPORATION: COMPANY OVERVIEW 161
12.2.3 AKERN 162
TABLE 181 AKERN: COMPANY OVERVIEW 162
12.2.4 WITHINGS 162
TABLE 182 WITHINGS: COMPANY OVERVIEW 162
12.2.5 XIAOMI 163
TABLE 183 XIAOMI: COMPANY OVERVIEW 163
12.2.6 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD. 163
TABLE 184 SINO-HERO (SHENZHEN) BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY OVERVIEW 163
12.2.7 LUMSAIL INDUSTRIAL INC. 164
TABLE 185 LUMSAIL INDUSTRIAL INC.: COMPANY OVERVIEW 164
12.2.8 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD. 164
TABLE 186 GUANGZHOU BEAUTYLIFE ELECTRONIC TECHNOLOGY CO., LTD.:
COMPANY OVERVIEW 164
12.2.9 BIOPARHOM 165
TABLE 187 BIOPARHOM: COMPANY OVERVIEW 165
12.2.10 MICROLIFE 165
TABLE 188 MICROLIFE: COMPANY OVERVIEW 165
13 APPENDIX 166
13.1 DISCUSSION GUIDE 166
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 170
13.3 AVAILABLE CUSTOMIZATIONS 172
13.4 RELATED REPORTS 172
13.5 AUTHOR DETAILS 173